Navigation Links
Nautilus Neurosciences and Tribute Pharmaceuticals Announce Exclusive Canadian License for CAMBIA™ (diclofenac potassium for oral solution) for the Acute Treatment of Migraine
Date:11/16/2010

ith their treatment and fewer than a fifth of people who suffer migraines describing themselves as "very satisfied" with their treatment.

A novel, water-soluble, buffered diclofenac potassium powder, CAMBIA™ is the only prescription non - steroidal anti-inflammatory drug (NSAID) available for the acute treatment of migraine.  Engineered using Dynamic Buffering Technology™ (DBT), a patented absorption-enhancing technology developed by APR Applied Pharma Research S.A., CAMBIA™ is specifically designed for fast, effective relief from the symptoms of migraine. CAMBIA™ enters the bloodstream quickly and readily achieves peak plasma concentrations, providing pain relief in fifteen minutes for some patients.

About Nautilus Neurosciences, Inc.

Nautilus Neurosciences is a neurology-focused specialty pharmaceutical company committed to providing the health care community with medically relevant products and services that directly benefit those affected by neurologic disorders.  Nautilus is backed by Tailwind Capital and Galen Partners.  

For more information, please visit www.nautilusneurosciences.com.

About Tribute Pharmaceuticals, Inc.

Tribute Pharmaceuticals is a specialty pharmaceutical company engaged in the acquisition, licensing and management of pharmaceuticals products in Canada. Tribute is committed to providing patients and physicians with clinically proven pharmaceuticals products that treat recognized medical conditions and diseases.  Tribute Pharma is a privately held Canadian company.  For more information please visit http://www.tributepharma.ca.

Unites States Indication

CAMBIA is a non-steroidal anti-inflammatory drug (NSAID) indicated for the acute treatment of migraine attacks with or without aura in adults 18 years of age or older.

'/>"/>
SOURCE Nautilus Neurosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Nautilus Neurosciences and Mission Pharmacal Announce Exclusive Co-Promotion Agreement for CAMBIA™ (diclofenac potassium for oral solution) for the Acute Treatment of Migraine to the Womens Health Market
2. US WorldMeds Acquires Solstice Neurosciences
3. Blanchette Rockefeller Neurosciences Institute and Inverness Medical Innovations to Develop Commercial Test to Detect Early Alzheimers Disease
4. Intellect Neurosciences, Inc. Announces Independent Studies on Copper Binding Properties of its Lead Candidate OXIGON(TM)
5. Neurosciences Institute Discovers Drug Extends Stroke Treatment Time to 24 Hours, Repairs Brain Tissue
6. Intellect Neurosciences, Inc. and Medical Research Council Technology (U.K.) Reach Important Milestone in Generating an Alzheimers Therapeutic Antibody
7. Knopp Neurosciences Receives Orphan Designation for KNS-760704 for Treatment of ALS
8. Knopp Neurosciences Initiates Phase 1 Clinical Trial of KNS-760704 in ALS Development Program
9. Intellect Neurosciences, Inc. and CHDI, Inc. Enter Into Compound Testing Agreement to Evaluate OXIGON(TM) as a Potential Treatment for Huntington Disease
10. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
11. Onyx Pharmaceuticals Reports Third Quarter 2010 Financial Results; Japan License Leverages Worldwide Potential of Carfilzomib and Contributes $59.2 Million of License Revenue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... -- Research and Markets  has announced the addition of ... report to their offering. ... drug market has been expanding rapidly owing to the ... During 2005-2013, sales of recombinant protein drugs available in ... and it is projected that China ...
(Date:11/21/2014)... 21, 2014  Alere Inc. (NYSE: ALR ... appointed Juliet Cunningham as Vice President, Investor ... responsible for driving communications with the investment community. ... of changes to increase shareholder value, it is critical ... Namal Nawana, Chief Executive Officer. "We are delighted that ...
(Date:11/21/2014)... and VIENNA, Va. , Nov. ... care provider that operates in Southern California ... provider of remote caregiving technology. Alta will be providing ... client receiving homecare services. Logo - ... is the key to providing the kind of affordable ...
Breaking Medicine Technology:China Recombinant Protein Drug Industry Report, 2014-2017 2China Recombinant Protein Drug Industry Report, 2014-2017 3Alere Appoints Juliet Cunningham to Lead Investor Relations 2Alta Home Care, Inc. and BeClose Partner to Enable Seniors to Remain in Their Homes Safely and Securely 2
... Two Large Phase III Trials Confirm Robust Efficacy ... announced today the results of new,Phase III data ... at the American,College of Rheumatology Annual Scientific Meeting ... only PEGylated Fc-free,anti-TNF (Tumor Necrosis Factor), given with ...
... imatinib,mesylate, more commonly known as Gleevec(R), proves safe and ... form of chronic myeloid leukemia,(CML), according to a study ... Society of Hematology., A team of researchers from ... MD, followed 454 patients with chronic-phase CML,taking imatinib for ...
Cached Medicine Technology:CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 2CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 3CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 4CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 5CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 6CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 7CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 8Leukemia Drug Proves Safe and Effective Over the Long Term 2
(Date:11/22/2014)... 2014 A new AlignLife Chiropractic & ... the downtown Greenville area. Dr. Chelsea Sineath, owner and ... to open her own clinic after working in another ... patients. , AlignLife believes that the body can ... focus on chiropractic care and rehabilitation to allow the ...
(Date:11/22/2014)... November 23, 2014 Recently, UWDress.com, a successful ... formal wedding guest attire in order to prepare for ... prices, up to 70% off. , UWDress.com is a ... are very beautiful, especially the new items -- formal wedding ... in the current market, including superstar and princess. As one ...
(Date:11/22/2014)... November 23, 2014 BambooFlooringChina.com is ... company has proudly released its new collection of bamboo ... rates, up to 29% off. , According to ... sturdy tree-like grass, making it a highly renewable resource. Their ... have a mixing color which comes from natural bamboo with ...
(Date:11/22/2014)... (PRWEB) November 22, 2014 “Due to my ... an inventor, from Gurnee, Ill. “While using the ice grip ... and I thought there needed to be a safer way ... the SPIKE BLOCK. , The SPIKE BLOCK offers added safety ... it would help to reduce injuries and damage associated with ...
(Date:11/22/2014)... Nocturia is defined by the International ... individual has to wake at night one or ... Pipeline Review, H2 2014” provides comprehensive information on ... analysis at various stages, therapeutics assessment by drug ... (RoA) and molecule type, along with latest updates, ...
Breaking Medicine News(10 mins):Health News:AlignLife of Downtown Greenville is Now Open and Accepting New Patients 2Health News:Formal Wedding Guest Attire Added to UWDress.com 2Health News:Trendy Bamboo Mats Online Now By BambooFlooringChina.com 2Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 2Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 3Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 4
... June 28 (HealthDay News) -- The time it takes ... emergency coronary angioplasty was greatly reduced when a statewide ... study finds. It included 436 patients with ST-elevation ... attack that occurs when a large area of the ...
... international team of researchers says abortion stigma is under-researched, ... who,ve had abortions. As a result, they,re launching a ... surrounding abortion. Their invited paper, "Abortion Stigma: ... in the current journal, Women,s Health Issues ...
... TUESDAY, June 28 (HealthDay News) -- Many members of low-income ... new study shows. In assessing the families, eating patterns ... that more than 70 percent of the 100 families, who ... to consume adequate amounts of several vital nutrients, including vitamins ...
... of scheduling chemotherapy treatments has been substantially reduced by a ... from the Sauder School of Business at the University of ... Called Chemo SmartBook, the innovative new scheduling system ... from the Health Employers Association of British Columbia in the ...
... , TUESDAY, June 28 (HealthDay News) -- ,A new study ... risk of death from heart disease than whites: Blacks appear to ... up in arteries and is not detected in standard screening. ... accumulate deep in the walls of arteries -- can rupture and ...
... many years against allergic rhinitis. Still, there has been ... seasonal allergic rhinitis (hay fever), particularly in children. Now, ... of Plant and Environmental Sciences at the University of ... of seasonal allergic rhinitis in children, without any adverse ...
Cached Medicine News:Health News:Program Shrinks Time-to-Treatment for Heart Attack: Study 2Health News:International team explores the stigma surrounding abortion 2Health News:Low-Income Families Often Miss Out on Proper Nutrition 2Health News:Innovative UBC-BC Cancer Agency system reduces waitlisting for chemotherapy patients 2Health News:Innovative UBC-BC Cancer Agency system reduces waitlisting for chemotherapy patients 3Health News:Study Hints at Why Heart Disease Is More Deadly for Blacks 2Health News:Children's hay fever relieved by cellulose power without adverse effects 2
... a unique wrap around design which fits ... for optimum coverage. The ratchet style ... up and down for a comfortable fit. ... to the Model #67, however, the ultra-lite ...
A soft vinyl goggle with limited splash protection due to its contoured facial fit. With leaded side shields added for increased scatter radiation protection. The mask easily fits over existing glass...
... wrap frame is constructed of extremely durable ... potential breakage. The molded wrap around ... saddle bridge to distribute weight evenly over ... with leaded glass side shields. Also ...
All New Ultra Pb Series Glasses...
Medicine Products: